FDA,
Piggy,
RSR,
Seed,
Risk,
Myoglobin,
Genetic engineering,
USDA,
Carbon,
Animal,
Plant,
CFR,
Movement,
Membrane protein,
Genetic distance,
APHIS,
Biotechnology Luxembourg, Apr 22, 2024 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC)("The company"), a Molecular Farming food-ingredient company, announced today that the Animal and Plant Health Inspection Service ("APHIS") of the U.S. Department of Agriculture ("USDA") has concluded its Regulatory Status Review ("RSR") for Moolec's genetically engineered ("GE") soybean Piggy Sooy(TM).
Key Points:
- Luxembourg, Apr 22, 2024 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC)("The company"), a Molecular Farming food-ingredient company, announced today that the Animal and Plant Health Inspection Service ("APHIS") of the U.S. Department of Agriculture ("USDA") has concluded its Regulatory Status Review ("RSR") for Moolec's genetically engineered ("GE") soybean Piggy Sooy(TM).
- The USDA-APHIS RSR determines that Moolec's genetically engineered soybean, accumulating animal meat protein, is unlikely to pose an increased plant pest risk relative to non-engineered soybeans.
- We achieved an unprecedented milestone in biotechnology with the first-ever USDA-APHIS approval of this kind," stated Gaston Paladini, Moolec Science's CEO & Co-Founder.
- By adding a well-known animal meat protein (porcine myoglobin) to the standard soybean proteins, the company expects to provide food manufacturers with a unique ingredient that will have a positive carbon and water footprint.
Retrieved on:
Wednesday, March 13, 2024
4M,
Conference,
Farmer,
Growth,
MLEC,
Research,
Seed,
Genetic distance,
Marketing,
Plant,
Conference call,
Myoglobin,
Quarter,
Fiscal,
Internet service provider Luxembourg, Mar 13, 2024 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023.
Key Points:
- Luxembourg, Mar 13, 2024 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023.
- The main highlights of Moolec's business update are as follows:
- SOOY1 | Piggy Sooy(TM) Platform: Third generation (T3) soybean seed propagation has started, and fourth generation (T4) seeds are expected to be harvested in April 2024.
- - PEEA1: Scientific team confirms the presence of bovine myoglobin gene in pea seeds and the gene's stable inheritance across plant generations.
- Thank you to the Moolers, and to our partners for their continued support," stated Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec Science.
Retrieved on:
Thursday, December 14, 2023
Luxembourg, Dec 14, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the first quarter of Fiscal Year 2024 ended September 30, 2023.
Key Points:
- Luxembourg, Dec 14, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the first quarter of Fiscal Year 2024 ended September 30, 2023.
- The main highlights of Moolec's business update are as follows:
- GLASO: Moolec harvested 35 hectares with a yield of 1.8 tons per hectare.
- For a full version of Moolec's first quarter Fiscal Year 2024 Business Update, click here.
- For a full version of Moolec's first quarter Fiscal Year 2024 Business Update, click here.
Retrieved on:
Saturday, October 21, 2023
FDA,
Food industry,
Conference,
Genetic distance,
ID,
MLEC,
Plant,
Molecular biology,
Conference call,
Seed,
Vegetable oil,
Pharmaceutical industry,
Internet service provider,
Fiscal Luxembourg, Oct 21, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its Business Update for the fourth quarter of Fiscal Year 2023 ended June 30, 2023.
Key Points:
- Luxembourg, Oct 21, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its Business Update for the fourth quarter of Fiscal Year 2023 ended June 30, 2023.
- The main highlights of the Company's business update are as follows:
- Piggy Sooy(TM): introducing a soybean platform that can produce high amounts of pork protein.
- These commitments will drive Moolec's business model forward through additional liquidity and enhanced capabilities," said Jose Lopez Lecube, Chief Financial Officer and Director of Moolec Science.
- For a full version of Moolec's fourth quarter Fiscal Year 2023 Business Update, click here.
Taste,
Food,
Food industry,
Seed,
Genetic distance,
Science,
Plant,
Protein,
Patent,
MLEC,
Soybean,
Meat,
Economics,
Fine chemical The animal protein reached a high expression level up to 26.6% of total soluble protein in soy seeds, 4x higher than initially projected by the Company.
Key Points:
- The animal protein reached a high expression level up to 26.6% of total soluble protein in soy seeds, 4x higher than initially projected by the Company.
- After this achievement, the Company's soybean platform was renamed "Piggy Sooy".
- With this groundbreaking achievement, Moolec consolidates its position as a category creator and a pioneer in Molecular Farming for the food industry.
- Moolec Science is producing several meat proteins in plants as functional ingredients to improve the taste, appearance, texture, and nutrition of meat alternatives.
Sustainability,
Food industry,
Genetic distance,
Research,
Plant,
Conference call,
USDA,
Maxim Integrated,
MOU,
HB4,
GLA,
MLEC,
PDF,
Conference,
Regulation,
Fiscal,
Security (finance),
Fine chemical,
Vegetable oil,
Management Luxembourg, May 31, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ: MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its business update for the third quarter of Fiscal Year 2023 ended March 31, 2023.
Key Points:
- Luxembourg, May 31, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ: MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its business update for the third quarter of Fiscal Year 2023 ended March 31, 2023.
- The main highlights of the Company's business update are as follows:
- On January 3, the Company started trading on Nasdaq under tickers "MLEC" for the common shares, and "MLECW" for the Company's warrants.
- - Integration of downstream and upstream capabilities:
-- Moolec acquired plant-based ingredient capabilities to consolidate Molecular Farming Technology.
- For a full version of Moolec Third Quarter Fiscal Year 2023 Business Update, click here.
Luxembourg, Apr 18, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today it has entered into a Share Purchase Agreement ("Agreement") with Nomura Securities International, Inc. ("Nomura").
Key Points:
- Luxembourg, Apr 18, 2023 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today it has entered into a Share Purchase Agreement ("Agreement") with Nomura Securities International, Inc. ("Nomura").
- The Company intends to use the proceeds from any future sales of securities under the financing facility, if it is utilized, for general corporate purposes.
- "We are pleased to partner with Nomura and secure this financing facility," said Jose Lopez Lecube, Moolec Science's Chief Financial Officer.
- "This new understanding provides Moolec with enhanced financial flexibility to continue driving forward our Molecular Farming Platform and portfolio of products," he concluded.
